{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-22-000117","form_type":"8-K","ticker":"CL","cik":"0000021665","company_name":"COLGATE PALMOLIVE CO","filed_at":"2022-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.150166+00:00","generated_at":"2026-06-27T14:23:08.304240+00:00","sec_items":["2.02","2.05","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Colgate Q4/FY2021: organic sales +4.5% FY; GAAP EPS down 19% on impairment; launches $200-240M productivity plan","bullets":["Full year net sales $17.42B (+6.0% YoY); organic sales growth +4.5%.","GAAP diluted EPS $2.55 (-19% YoY) due to Filorga goodwill impairment; base business EPS $3.21 (+5%).","Q4 net sales +2.0%, organic +3.0%; oral care and pet nutrition accelerated.","Board approved 2022 Global Productivity Initiative; estimated pre-tax charges $200-240M (80% severance), substantially complete by Dec 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-22-000117","json":"https://secwatch.observer/filing/0001157523-22-000117.json","markdown":"https://secwatch.observer/filing/0001157523-22-000117.md","text":"https://secwatch.observer/filing/0001157523-22-000117.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/21665/000115752322000117/0001157523-22-000117-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/21665/000115752322000117/a52570001.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T14:23:08.304240+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}